Sartorius Reports Strong Start to 2026 with Revenue Growth

In the first quarter of 2026, Sartorius AG has experienced a 7.5% increase in group sales revenue, reaching 899 million euros. This growth was primarily fueled by the Bioprocess Solutions Division, which saw an 8.1% rise, and the Lab Products & Services Division, which grew by 4.9%. The company's profit margin remains steady with an underlying EBITDA margin of 29.7%.

Sartorius CEO Dr. Michael Grosse credits the growth to the expansion of the recurring consumables business and forecasts improvements in the equipment and instruments sector within the year. Despite geopolitical tensions and macroeconomic uncertainties, the company maintains its full-year guidance for 2026.

All geographical regions contributed positively to revenue growth. The EMEA region rose by 8.0%, the Americas by 6.0%, and Asia/Pacific ended the quarter with an 8.9% increase. Additionally, employment figures climbed, with the company hiring 200 new employees.